Peter Greiner

CEO & Co-Founder at dawn-bio

Presenter

What if every IVF cycle could lead to a healthy baby? That’s the vision Dr. Peter Greiner is working toward as Co-Founder and CEO of dawn-bio. With his Vienna based biotech team he is redefining what is possible in human reproduction to dramatically improve IVF outcomes over the coming years. Peter brings deep domain expertise and proven leadership: he previously led Merck Healthcare’s €1.6B global fertility business as Senior Vice President, across R&D, manufacturing, and commercial, delivering record market shares and sales. Today, he also chairs the supervisory board of FamiCord AG, Europe’s largest human stem-cell bank. A biochemist by training, an award-winning business school professor by passion, and a builder in every sense - of teams, businesses, technologies and even furnitures, timber-framed houses and zip-lines - Peter brings together scientific curiosity, hands-on execution, and a deep sense of purpose to tackle one of the most pressing and human challenges of our time. At Bio-Europe, he shares how dawn-bio is unlocking the next leap in fertility—and why now is the time to invest in a future where every patient has a real chance to bring home a healthy baby.